The Vivos experience of ""failures"" and missteps is not unique simply because there are many well funded MedTechs and Biotechs in similar positions and worse re their standing with the FDA that trade on higher Exchanges.
The problem with you noobs is the grossly false impression you all have that this process is somehow a routine and overnight one and as such many statements are made out of pure ignorance.......Vivos isn't a Lily, Pfizer or Moderna etc etc to be afforded special privileges as the latter still enjoy.
I suggest you look into my claims and be assured that they are not unfounded.
Market Data 
Markets 
AI
